<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One way to link <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> is through the intrinsic inflammatory pathway, in which genetic alterations that induce <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> also produce a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-promoting, inflammatory microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>Signal transducer and activator of transcription 3 (STAT3) contributes to the intrinsic inflammatory pathway in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, honokiol (a <z:chebi fb="0" ids="26195">polyphenol</z:chebi> in herbal teas) has growth-inhibitory and proapoptotic effects associated with suppressed activation of STAT3 </plain></SENT>
<SENT sid="3" pm="."><plain>We used human Barrett's epithelial and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cell lines to determine effects of honokiol on cell number, <z:mp ids='MP_0001651'>necrosis</z:mp>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and anchorage-independent growth and to explore STAT3's role in those effects </plain></SENT>
<SENT sid="4" pm="."><plain>We determined Ras activity and expression of phosphorylated ERK1/2, phosphorylated Akt, and phosphorylated STAT3 in the presence or absence of honokiol </plain></SENT>
<SENT sid="5" pm="."><plain>Cells were infected with constitutively active Stat3-C to assess effects of honokiol-induced STAT3 inhibition on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Honokiol <z:mp ids='MP_0000329'>decreased cell number</z:mp> and increased <z:mp ids='MP_0001651'>necrosis</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in transformed Barrett's cells, but not in nontransformed cells </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells, honokiol also increased <z:mp ids='MP_0001651'>necrosis</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and decreased anchorage-independent growth </plain></SENT>
<SENT sid="8" pm="."><plain>Within 30 min of honokiol treatment, transformed Barrett's cells decreased expression of phosphorylated STAT3; decreases in Ras activity and phosphorylated ERK1/2 expression were detected at 24 h </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> with Stat3-C significantly <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> after honokiol treatment </plain></SENT>
<SENT sid="10" pm="."><plain>Honokiol causes <z:mp ids='MP_0001651'>necrosis</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in transformed Barrett's and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells, but not in nontransformed Barrett's cells, and the proapoptotic effects of honokiol are mediated by its inhibition of STAT3 signaling </plain></SENT>
<SENT sid="11" pm="."><plain>These findings suggest a potential role for targeting the intrinsic inflammatory pathways as a therapeutic strategy to prevent Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>